Craig A. Johnson is Director at Mirati Therapeutics, Inc. (MRTX). They have made 4 open-market trades across 2 companies since 2011, most recently 2026-01-30.
CIK 0001370348
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $51K since 2020, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HRTX | SELL · 10b5-1 | 2021-12-21 | 2021-12-23 | $9.73 | $2K | -11.9% | -15.9% | -46.3% |
| HRTX | SELL · 10b5-1 | 2021-09-21 | 2021-09-23 | $12.30 | $3K | -17.9% | -18.9% | -22.0% |
| HRTX | SELL · 10b5-1 | 2021-06-21 | 2021-06-22 | $15.20 | $4K | -6.4% | -17.9% | -23.5% |
| HRTX | SELL · 10b5-1 | 2021-04-06 | 2021-04-07 | $17.22 | $4K | -0.4% | -3.4% | -16.3% |
| MRTX | SELL | 2021-01-21 | 2021-01-25 | $211.55 | $6.3M | -6.4% | -5.3% | -25.2% |
| ODT | BUY | 2020-12-29 | 2020-12-31 | $17.00 | $51K | -5.9% | +9.5% | -83.8% |
| MRTX | SELL | 2020-04-20 | 2020-04-21 | $93.00 | $1.4M | -5.8% | +14.9% | +45.7% |
| MRTX | SELL | 2019-01-29 | 2019-01-31 | $61.34 | $1.6M | +9.4% | +10.2% | -9.3% |
| RDEA | SELL · 10b5-1 | 2011-08-01 | 2011-08-02 | $23.16 | $23K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2011-07-01 | 2011-07-05 | $26.24 | $52K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.